相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment
Weiting Ge et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer
Nathaniel L. Jones et al.
GYNECOLOGIC ONCOLOGY (2020)
Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer
Hu Fang et al.
PLOS GENETICS (2020)
POLE proofreading defects: Contributions to mutagenesis and cancer
Vivian S. Park et al.
DNA REPAIR (2019)
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer
Jennifer Taylor Veneris et al.
GYNECOLOGIC ONCOLOGY (2019)
Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene
Hitoshi Hino et al.
CANCER MEDICINE (2019)
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Laura Fancello et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types
Feng Wang et al.
JAMA ONCOLOGY (2019)
Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures
Ester Castellsague et al.
HUMAN MUTATION (2019)
POLD1 and POLE Gene Mutations in Jewish Cohorts of Early-Onset Colorectal Cancer and of Multiple Colorectal Adenomas
Guy Rosner et al.
DISEASES OF THE COLON & RECTUM (2018)
Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load
Hao-Dong Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Laetitia Nebot-Bral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B. Campbell et al.
CELL (2017)
A panoply of errors: polymerase proofreading domain mutations in cancer
Emily Rayner et al.
NATURE REVIEWS CANCER (2016)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Enric Domingo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers
Sarah Briggs et al.
JOURNAL OF PATHOLOGY (2013)
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
Claire Palles et al.
NATURE GENETICS (2013)
分享论文
